HEADER HYDROLASE/HYDROLASE INHIBITOR 26-AUG-11 3TKG TITLE CRYSTAL STRUCTURE OF HIV MODEL PROTEASE PRECURSOR/SAQUINAVIR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 EC: 3.4.23.16; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1; SOURCE 3 ORGANISM_COMMON: HIV-1; SOURCE 4 ORGANISM_TAXID: 11686; SOURCE 5 GENE: GAG-POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.AGNISWAMY,J.SAYER,I.WEBER,J.LOUIS REVDAT 3 13-SEP-23 3TKG 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 HETSYN REVDAT 2 08-NOV-17 3TKG 1 REMARK REVDAT 1 25-APR-12 3TKG 0 JRNL AUTH J.AGNISWAMY,J.M.SAYER,I.T.WEBER,J.M.LOUIS JRNL TITL TERMINAL INTERFACE CONFORMATIONS MODULATE DIMER STABILITY JRNL TITL 2 PRIOR TO AMINO TERMINAL AUTOPROCESSING OF HIV-1 PROTEASE. JRNL REF BIOCHEMISTRY V. 51 1041 2012 JRNL REFN ISSN 0006-2960 JRNL PMID 22242794 JRNL DOI 10.1021/BI201809S REMARK 2 REMARK 2 RESOLUTION. 1.36 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.36 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.163 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.163 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 4335 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 86762 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : NULL REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE (F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3096 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 108 REMARK 3 SOLVENT ATOMS : 260 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : NULL REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : NULL REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : NULL REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : NULL REMARK 3 NUMBER OF RESTRAINTS : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 ANGLE DISTANCES (A) : 0.030 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : NULL REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : NULL REMARK 3 ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : NULL REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : NULL REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : NULL REMARK 3 SIMILAR ADP COMPONENTS (A**2) : NULL REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3TKG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1000067588. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8 REMARK 200 MONOCHROMATOR : SI 220 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 87215 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.360 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 34.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.36 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 59.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.45900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3OXC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.39 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.65M AMMONIUM CHLORIDE, 0.1M SODIUM REMARK 280 ACETATE, PH 4.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.03700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.08400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.47000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.08400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.03700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.47000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10400 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B -3 REMARK 465 PHE B -2 REMARK 465 ASN B -1 REMARK 465 PHE B 0 REMARK 465 SER D -3 REMARK 465 PHE D -2 REMARK 465 ASN D -1 REMARK 465 PHE D 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 87 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 PRO B 1 CA - N - CD ANGL. DEV. = -9.9 DEGREES REMARK 500 ARG B 57 CD - NE - CZ ANGL. DEV. = 21.4 DEGREES REMARK 500 ARG C 8 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG C 41 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG C 57 NE - CZ - NH2 ANGL. DEV. = 4.0 DEGREES REMARK 500 ARG C 87 NE - CZ - NH2 ANGL. DEV. = -4.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU C 34 151.86 -49.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- REMARK 630 BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H-ISOQUINOLIN-2-YL]-3- REMARK 630 HYDROXY-1 -PHENYL-BUTAN-2-YL]-2-(QUINOLIN-2-YLCARBONYLAMINO) REMARK 630 BUTANEDIAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 ROC B 801 REMARK 630 ROC C 901 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: QNC ASN HP0 NTB REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 911 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 921 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROC B 801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 913 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ROC C 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL C 912 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL D 914 DBREF 3TKG A -4 99 UNP P03367 POL_HV1BR 497 599 DBREF 3TKG B -3 99 UNP P03367 POL_HV1BR 497 599 DBREF 3TKG C -4 99 UNP P03367 POL_HV1BR 497 599 DBREF 3TKG D -3 99 UNP P03367 POL_HV1BR 497 599 SEQADV 3TKG LYS A 7 UNP P03367 GLN 507 CONFLICT SEQADV 3TKG ILE A 33 UNP P03367 LEU 533 CONFLICT SEQADV 3TKG ILE A 63 UNP P03367 LEU 563 CONFLICT SEQADV 3TKG ALA A 67 UNP P03367 CYS 567 CONFLICT SEQADV 3TKG ALA A 95 UNP P03367 CYS 595 CONFLICT SEQADV 3TKG LYS B 7 UNP P03367 GLN 507 CONFLICT SEQADV 3TKG ILE B 33 UNP P03367 LEU 533 CONFLICT SEQADV 3TKG ILE B 63 UNP P03367 LEU 563 CONFLICT SEQADV 3TKG ALA B 67 UNP P03367 CYS 567 CONFLICT SEQADV 3TKG ALA B 95 UNP P03367 CYS 595 CONFLICT SEQADV 3TKG LYS C 7 UNP P03367 GLN 507 CONFLICT SEQADV 3TKG ILE C 33 UNP P03367 LEU 533 CONFLICT SEQADV 3TKG ILE C 63 UNP P03367 LEU 563 CONFLICT SEQADV 3TKG ALA C 67 UNP P03367 CYS 567 CONFLICT SEQADV 3TKG ALA C 95 UNP P03367 CYS 595 CONFLICT SEQADV 3TKG LYS D 7 UNP P03367 GLN 507 CONFLICT SEQADV 3TKG ILE D 33 UNP P03367 LEU 533 CONFLICT SEQADV 3TKG ILE D 63 UNP P03367 LEU 563 CONFLICT SEQADV 3TKG ALA D 67 UNP P03367 CYS 567 CONFLICT SEQADV 3TKG ALA D 95 UNP P03367 CYS 595 CONFLICT SEQRES 1 A 103 SER PHE ASN PHE PRO GLN ILE THR LEU TRP LYS ARG PRO SEQRES 2 A 103 LEU VAL THR ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA SEQRES 3 A 103 LEU LEU ASP THR GLY ALA ASP ASP THR VAL ILE GLU GLU SEQRES 4 A 103 MET SER LEU PRO GLY ARG TRP LYS PRO LYS MET ILE GLY SEQRES 5 A 103 GLY ILE GLY GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN SEQRES 6 A 103 ILE ILE ILE GLU ILE ALA GLY HIS LYS ALA ILE GLY THR SEQRES 7 A 103 VAL LEU VAL GLY PRO THR PRO VAL ASN ILE ILE GLY ARG SEQRES 8 A 103 ASN LEU LEU THR GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 B 103 SER PHE ASN PHE PRO GLN ILE THR LEU TRP LYS ARG PRO SEQRES 2 B 103 LEU VAL THR ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA SEQRES 3 B 103 LEU LEU ASP THR GLY ALA ASP ASP THR VAL ILE GLU GLU SEQRES 4 B 103 MET SER LEU PRO GLY ARG TRP LYS PRO LYS MET ILE GLY SEQRES 5 B 103 GLY ILE GLY GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN SEQRES 6 B 103 ILE ILE ILE GLU ILE ALA GLY HIS LYS ALA ILE GLY THR SEQRES 7 B 103 VAL LEU VAL GLY PRO THR PRO VAL ASN ILE ILE GLY ARG SEQRES 8 B 103 ASN LEU LEU THR GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 C 103 SER PHE ASN PHE PRO GLN ILE THR LEU TRP LYS ARG PRO SEQRES 2 C 103 LEU VAL THR ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA SEQRES 3 C 103 LEU LEU ASP THR GLY ALA ASP ASP THR VAL ILE GLU GLU SEQRES 4 C 103 MET SER LEU PRO GLY ARG TRP LYS PRO LYS MET ILE GLY SEQRES 5 C 103 GLY ILE GLY GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN SEQRES 6 C 103 ILE ILE ILE GLU ILE ALA GLY HIS LYS ALA ILE GLY THR SEQRES 7 C 103 VAL LEU VAL GLY PRO THR PRO VAL ASN ILE ILE GLY ARG SEQRES 8 C 103 ASN LEU LEU THR GLN ILE GLY ALA THR LEU ASN PHE SEQRES 1 D 103 SER PHE ASN PHE PRO GLN ILE THR LEU TRP LYS ARG PRO SEQRES 2 D 103 LEU VAL THR ILE LYS ILE GLY GLY GLN LEU LYS GLU ALA SEQRES 3 D 103 LEU LEU ASP THR GLY ALA ASP ASP THR VAL ILE GLU GLU SEQRES 4 D 103 MET SER LEU PRO GLY ARG TRP LYS PRO LYS MET ILE GLY SEQRES 5 D 103 GLY ILE GLY GLY PHE ILE LYS VAL ARG GLN TYR ASP GLN SEQRES 6 D 103 ILE ILE ILE GLU ILE ALA GLY HIS LYS ALA ILE GLY THR SEQRES 7 D 103 VAL LEU VAL GLY PRO THR PRO VAL ASN ILE ILE GLY ARG SEQRES 8 D 103 ASN LEU LEU THR GLN ILE GLY ALA THR LEU ASN PHE HET CL A 101 1 HET GOL A 102 6 HET ROC B 801 98 HET CL B 802 1 HET ROC C 901 98 HET CL C 902 1 HET CL D 101 1 HETNAM CL CHLORIDE ION HETNAM GOL GLYCEROL HETNAM ROC (2S)-N-[(2S,3R)-4-[(2S,3S,4AS,8AS)-3-(TERT- HETNAM 2 ROC BUTYLCARBAMOYL)-3,4,4A,5,6,7,8,8A-OCTAHYDRO-1H- HETNAM 3 ROC ISOQUINOLIN-2-YL]-3-HYDROXY-1 -PHENYL-BUTAN-2-YL]-2- HETNAM 4 ROC (QUINOLIN-2-YLCARBONYLAMINO)BUTANEDIAMIDE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN ROC FORTOVASE; SAQUINAVIR; RO 31-8959 FORMUL 5 CL 4(CL 1-) FORMUL 6 GOL C3 H8 O3 FORMUL 7 ROC 2(C38 H50 N6 O5) FORMUL 12 HOH *260(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLN A 92 GLY A 94 5 3 HELIX 3 3 GLY B 86 THR B 91 1 6 HELIX 4 4 GLY C 86 THR C 91 1 6 HELIX 5 5 GLN C 92 GLY C 94 5 3 HELIX 6 6 GLY D 86 THR D 91 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 THR B 96 ASN B 98 -1 O LEU B 97 N ILE A 3 SHEET 3 A 4 THR A 96 ASN A 98 -1 N THR A 96 O ASN B 98 SHEET 4 A 4 GLN B 2 ILE B 3 -1 O ILE B 3 N LEU A 97 SHEET 1 B 8 LYS A 43 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O ALA A 71 N ILE A 64 SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 13 O LYS A 20 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N LYS A 14 SHEET 1 C 8 TRP B 42 GLY B 49 0 SHEET 2 C 8 GLY B 52 ILE B 66 -1 O GLN B 58 N LYS B 43 SHEET 3 C 8 HIS B 69 VAL B 77 -1 O HIS B 69 N ILE B 66 SHEET 4 C 8 VAL B 32 ILE B 33 1 N ILE B 33 O LEU B 76 SHEET 5 C 8 ILE B 84 ILE B 85 -1 O ILE B 84 N VAL B 32 SHEET 6 C 8 GLN B 18 LEU B 24 1 N LEU B 23 O ILE B 85 SHEET 7 C 8 LEU B 10 ILE B 15 -1 N VAL B 11 O ALA B 22 SHEET 8 C 8 GLY B 52 ILE B 66 -1 O GLU B 65 N LYS B 14 SHEET 1 D 4 GLN C 2 ILE C 3 0 SHEET 2 D 4 THR D 96 ASN D 98 -1 O LEU D 97 N ILE C 3 SHEET 3 D 4 THR C 96 ASN C 98 -1 N THR C 96 O ASN D 98 SHEET 4 D 4 GLN D 2 ILE D 3 -1 O ILE D 3 N LEU C 97 SHEET 1 E 8 LYS C 43 GLY C 49 0 SHEET 2 E 8 GLY C 52 ILE C 66 -1 O VAL C 56 N LYS C 45 SHEET 3 E 8 HIS C 69 VAL C 77 -1 O VAL C 77 N ARG C 57 SHEET 4 E 8 VAL C 32 ILE C 33 1 N ILE C 33 O LEU C 76 SHEET 5 E 8 ILE C 84 ILE C 85 -1 O ILE C 84 N VAL C 32 SHEET 6 E 8 GLN C 18 LEU C 24 1 N LEU C 23 O ILE C 85 SHEET 7 E 8 LEU C 10 ILE C 15 -1 N ILE C 13 O LYS C 20 SHEET 8 E 8 GLY C 52 ILE C 66 -1 O GLU C 65 N LYS C 14 SHEET 1 F 8 TRP D 42 GLY D 49 0 SHEET 2 F 8 GLY D 52 ILE D 66 -1 O GLN D 58 N LYS D 43 SHEET 3 F 8 HIS D 69 VAL D 77 -1 O ALA D 71 N ILE D 64 SHEET 4 F 8 VAL D 32 ILE D 33 1 N ILE D 33 O LEU D 76 SHEET 5 F 8 ILE D 84 ILE D 85 -1 O ILE D 84 N VAL D 32 SHEET 6 F 8 GLN D 18 LEU D 24 1 N LEU D 23 O ILE D 85 SHEET 7 F 8 LEU D 10 ILE D 15 -1 N ILE D 13 O LYS D 20 SHEET 8 F 8 GLY D 52 ILE D 66 -1 O GLU D 65 N LYS D 14 SITE 1 AC1 3 THR A 74 ASN A 88 ARG D 41 SITE 1 AC2 4 LYS A 45 MET A 46 ILE A 47 GLN B 61 SITE 1 AC3 25 TRP A 6 ARG A 8 ASP A 25 GLY A 27 SITE 2 AC3 25 ALA A 28 ASP A 29 ASP A 30 GLY A 48 SITE 3 AC3 25 GLY A 49 ILE A 50 THR A 80 PRO A 81 SITE 4 AC3 25 ILE A 84 ARG B 8 ASP B 25 GLY B 27 SITE 5 AC3 25 ASP B 29 ASP B 30 ILE B 47 GLY B 48 SITE 6 AC3 25 GLY B 49 ILE B 50 THR B 80 PRO B 81 SITE 7 AC3 25 ILE B 84 SITE 1 AC4 2 THR B 74 ASN B 88 SITE 1 AC5 26 TRP C 6 ARG C 8 ASP C 25 GLY C 27 SITE 2 AC5 26 ALA C 28 ASP C 29 ASP C 30 ILE C 47 SITE 3 AC5 26 GLY C 48 GLY C 49 ILE C 50 THR C 80 SITE 4 AC5 26 ILE C 84 HOH C1004 HOH C1010 ARG D 8 SITE 5 AC5 26 ASP D 25 GLY D 27 ASP D 29 ASP D 30 SITE 6 AC5 26 ILE D 47 GLY D 48 GLY D 49 ILE D 50 SITE 7 AC5 26 PRO D 81 ILE D 84 SITE 1 AC6 3 ARG B 41 THR C 74 ASN C 88 SITE 1 AC7 3 GLY D 73 THR D 74 ASN D 88 CRYST1 80.074 88.940 60.168 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012488 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011244 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016620 0.00000